World's Best Scientists 2026 revealed!

Thomas J. Ketas publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Thomas J. Ketas sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

The last bar groups every scientist with 679 publications or more.

Thomas J. Ketas D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas J. Ketas sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

The last bar groups every scientist with 127 D-Index or more.

Overview

Thomas J. Ketas is affiliated with Cornell University in the United States. Their research spans key areas within the fields of Medicine and Immunology and Microbiology, with a focus on Infectious Diseases, Virology, Immunology, Epidemiology, and Oncology. The scientist's main research topics include HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction, SARS-CoV-2 detection and testing, and Immunotherapy and Immune Responses.

Among their recent publications are:

  • "T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers" (2020, Nature Medicine)
  • "Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva" (2021, Pathogens and Immunity)
  • "Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens" (2020, PLoS Pathogens)
  • "Predictors of Nonseroconversion after SARS-CoV-2 Infection" (2021, Emerging infectious diseases)
  • "Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva" (2021, bioRxiv [Cold Spring Harbor Laboratory])

Thomas J. Ketas has collaborated frequently with several researchers, including John P. Moore, Per Johan Klasse, Andrew B. Ward, Anila Yasmeen, and Zhen Zhao.

The scientist's publications have appeared in venues such as bioRxiv (Cold Spring Harbor Laboratory), PLoS Pathogens, PubMed, Nature Medicine, and Pathogens and Immunity.

Best Publications

  • A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies

    Rogier W. Sanders;Rogier W. Sanders;Ronald Derking;Albert Cupo;Jean-Philippe Julien

  • Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120

    Ronald S. Veazey;Robin J. Shattock;Melissa Pope;J. Christian Kirijan

  • HIV-1 neutralizing antibodies induced by native-like envelope trimers

    Rogier W. Sanders;Rogier W. Sanders;Marit J. Van Gils;Ronald Derking;Devin Sok;Devin Sok

  • Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.

    Wesley C. Van Voorhis;John H. Adams;Roberto Adelfio;Roberto Adelfio;Vida Ahyong

  • HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

    Alexandra Trkola;Shawn E. Kuhmann;Julie M. Strizki;Elizabeth Maxwell

  • Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.

    Ronald S. Veazey;Per Johan Klasse;Susan M. Schader;Qinxue Hu

  • Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140

    Alexandra Trkola;Thomas J. Ketas;Kirsten A. Nagashima;Lu Zhao

  • HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits

    Weifeng Xu;Paul A Santini;John S Sullivan;Bing He

  • Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers

    W. Seth Horne;Lisa M. Johnson;Thomas J. Ketas;Per Johan Klasse

  • Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry

    Fotini Tsamis;Svetlana Gavrilov;Francis Kajumo;Christoph Seibert

  • HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

    Gabriel M. Ortiz;Douglas F. Nixon;Alexandra Trkola;James Binley

  • A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene

    Pavel Pugach;Gabriel Ozorowski;Albert Cupo;Rajesh Ringe

  • The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C

    Tonie Cilliers;Jabulani Nhlapo;Mia Coetzer;Dragana Orlovic

  • HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry

    Pavel Pugach;Andre J. Marozsan;Thomas J. Ketas;Elissa L. Landes

  • Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency

    Paolo Ingallinella;Elisabetta Bianchi;Neal A. Ladwa;Ying-Jie Wang

  • Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

    Jeffrey M. Jacobson;Israel Lowy;Courtney V. Fletcher;Tobias J. O'Neill

  • Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle.

    Philip J. M. Brouwer;Aleksandar Antanasijevic;Zachary Berndsen;Anila Yasmeen

  • Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.

    Ronald S. Veazey;Thomas J. Ketas;Jason Dufour;Terri Moroney-Rasmussen

  • Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.

    Ronald S. Veazey;Per Johan Klasse;Thomas J. Ketas;Jacqueline D. Reeves

  • Evaluating the Immunogenicity of a Disulfide-Stabilized, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1

    Simon Beddows;Norbert Schülke;Marc Kirschner;Kelly Barnes

Frequent Co-Authors

Rogier W. Sanders
Rogier W. Sanders University of Amsterdam
Max Crispin
Max Crispin University of Southampton
Celia C. LaBranche
Celia C. LaBranche Duke University
William C. Olson
William C. Olson Regeneron (United States)
Marit J. van Gils
Marit J. van Gils University of Amsterdam
Jesse D. Bloom
Jesse D. Bloom Fred Hutchinson Cancer Research Center
Jean-Philippe Julien
Jean-Philippe Julien University of Toronto
Paul D. Bieniasz
Paul D. Bieniasz Rockefeller University
Stephen Baker
Stephen Baker Agency for Science, Technology and Research
Beatrice H. Hahn
Beatrice H. Hahn University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to microbiology can open doors to diverse career paths beyond traditional laboratory roles. For instance, those interested in healthcare may consider programs leading to becoming a functional medicine nurse practitioner, a growing field that integrates holistic care with scientific knowledge.

Additionally, careers like a certified professional coder offer opportunities in medical billing and coding, which benefit greatly from a solid understanding of biological and medical terminology. This path is well-suited for those seeking stable healthcare industry roles.

For students concerned about background challenges, online programs highlighted in degrees for felons offer accessible learning routes and career options designed to overcome barriers and provide second chances.

Careers such as a child life specialist also demand specialized knowledge and offer meaningful work environments, with competitive child life specialists salary reflecting their unique role in healthcare settings. Overall, online study options related to microbiology provide flexible pathways tailored to various interests and circumstances.

Best Scientists Citing Thomas J. Ketas

Trending Scientists

Recently Published Articles